-
@ Layer3.news
2025-06-17 15:37:21
nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy
WELLS FARGO REMAINS BULLISH ON CVS HEALTH (CVS) WITH AN $84 PT
https://s.yimg.com/ny/api/res/1.2/d6hiuhfSWIMOKtD72OdXqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f
--
✍️ Wells Fargo analyst Stephen Baxter maintains a Buy rating on CVS Health Corporation, citing strong Q1 2025 results with 7% revenue growth and increased EPS.
--
👉 CVS Health Corporation reported strong Q1 2025 results
👉 Total revenues increased by 7% to $94.6 billion
👉 GAAP diluted EPS of $1.41, up from $0.88 in the prior year
👉 Adjusted EPS of $2.25 for fiscal Q1 2025, up from $1.31 in the prior year
👉 Company raised its adjusted EPS guidance range to $6.00 to $6.20
--
#StephenBaxter #business
--
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqg8qext9wn9y2qnm9d2ptwvsdquw762766dus8kcutx33sa5e4ku2u3l7560